Physician profile
Michael J Semidey
NPI 1780963769
$6,559.36
in general payments reported to CMS, 2019-2025
9 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 87% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,479 · 2020: $50.00 · 2021: $589 · 2022: $461 · 2023: $249 · 2024: $2,541 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,921 · Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,921.04 |
| Food and Beverage | $1,058.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $3,992.35 | 2022-2025 | |
| Axogen | $1,479.35 | 2019 | |
| Salvin Dental Specialties, INC. | $400.46 | 2021 | |
| Straumann USA LLC | $374.66 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $115.27 | 2020-2021 | |
| Depuy Synthes Sales INC. | $74.76 | 2022 | |
| Kls-Martin L.P. | $49.46 | 2022 | |
| Geistlich Pharma, North America, INC. | $38.71 | 2021 | |
| Stryker Corporation | $34.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Semidey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.